Clinical Trials Logo

Menopause, Premature clinical trials

View clinical trials related to Menopause, Premature.

Filter by:

NCT ID: NCT02757469 Not yet recruiting - Clinical trials for Primary Ovarian Insufficiency

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

Start date: May 2016
Phase: N/A
Study type: Interventional

Premature ovarian insufficiency (POI) is a life-changing condition that affects women in their reproductive age. There is a lack of reports which focus on how to improve the reproductive outcome of these women who wish to conceive spontaneously or use assisted conception with their own oocytes. However, one could surmise that it is important to lower gonadotropin levels into the physiological range before embarking on any treatment, even if natural conception is the only choice for the woman/couple.

NCT ID: NCT02696889 Completed - Clinical trials for Premature Ovarian Failure

Rejuvenation of Premature Ovarian Failure With Stem Cells

ROSE-1
Start date: February 6, 2016
Phase: N/A
Study type: Interventional

The ROSE-1 study is designed to determine the efficacy of bone marrow derived stem cell therapy on ovarian function recovery in subjects with idiopathic and other types of premature or primary ovarian failure (POF or POI) and low ovarian reserves.

NCT ID: NCT02644447 Completed - Clinical trials for Premature Ovarian Failure

Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF

Start date: October 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Cellular therapies are rapidly progressing fields and have shown immense promise in the treatment of damaged ovarian function. The purpose of this study is to determine safety and efficacy of intra-ovarian injection of allogeneic HUC-MSCs with injectable collagen scaffold in women with Premature Ovarian Failure (POF) and to study the preliminary efficacy of HUC-MSCs with injectable collagen scaffold injection on ovarian function improvement.

NCT ID: NCT02616510 Completed - Clinical trials for Cardiovascular Diseases

Primary Ovarian Insufficiency, Polycystic Ovary Syndrome & the CardiOvascular Risk Profile

POPCORn
Start date: July 2013
Phase:
Study type: Observational

The polycystic ovary syndrome (PCOS) is the most common endocrinopathy amongst women of reproductive age. PCOS is associated with various cardiovascular risk factors such as obesity, glucose intolerance, dyslipidemia hypertension and the metabolic syndrome. Whether these increased cardiovascular risk factors result in the development of actual cardiovascular disease in later life remains to be established. Women with premature ovarian insufficiency (POI), experience menopause prior to the age of 40 years. Women with POI may exhibit dyslipidemia. A young age at menopause has been previously associated with increased cardiovascular morbidity and mortality.

NCT ID: NCT02603744 Recruiting - Clinical trials for Premature Ovarian Failure

Autologous Adipose Derived Mesenchymal Stromal Cells Transplantation in Women With Premature Ovarian Failure (POF)

Start date: June 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to determine safety and tolerability and of intra-ovarian injection of adipose derived stromal cell in women with premature ovarian failure and to study the preliminary efficacy ADSCs intra ovarian injection on ovarian function improvement.

NCT ID: NCT02496598 Terminated - Infertility Clinical Trials

In Vitro Follicle Activation

IVA
Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of an experimental treatment, known as in vitro activation (IVA) of dormant ovarian follicles, for infertility in women diagnosed with primary ovarian insufficiency (POI).

NCT ID: NCT02467231 Active, not recruiting - Clinical trials for Premature Ovarian Failure

Ovarian Reserve After Cancer: Longitudinal Effects

ORACLE
Start date: February 2009
Phase:
Study type: Observational

Women of reproductive age who will receive treatment for cancer that includes chemotherapy may participate in a study measuring ovarian function over time. Eligible women are asked to complete a questionnaire, a menstrual diary, a brief physical examination, an ultrasound, and a blood test before, during and after cancer treatment.

NCT ID: NCT02372474 Completed - Clinical trials for Premature Ovarian Failure

"It is a Real" The First Baby Of Autologous Stem Cell Therapy in Premature Ovarian Failure

Start date: March 2012
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this work is to evaluate the therapeutic potential of Autologous Mesenchymal sc (MSC) therapy in women suffering from POF.

NCT ID: NCT02322060 Recruiting - Clinical trials for Primary Ovarian Insufficiency

In Vitro Activation of Dormant Follicles for Patients With Primary Ovarian Insufficiency

IVADFPOI
Start date: September 2014
Phase:
Study type: Observational [Patient Registry]

In this study, the investigators used the newly developed technique i.e. in vitro activation of dormant follicles (IVA) to promote ovarian follicle growth much more efficiently than natural, in vivo process for women with Primary Ovarian Insufficiency (POI).Firstly, the investigators remove one ovary under laparoscopic surgery. Then, we dissect ovarian cortex from the ovarian medulla. The ovarian cortex is cut into small cubes and cultured with medium containing drugs to activate dormant follicles. After 2 days of culture, the ovarian cubes are transplanted mainly beneath the membrane of Fallopian tubes under laparoscopic surgery. The ovarian cortex could be cryopreserve for future re-transplantation and in some cases, for convenience to arrange second surgery. Once frozen, the ovary can be preserved semipermanently. After transplantation, patients receive ultrasound monitoring together with measurement of serum hormone levels for 10-12 months. If growing follicles are detected, follicle growth is stimulated by injection of hormones (gonadotropins). Using the same "ovum pick up" approach used in IVF (in vitro fertilization), we pick up oocytes from the follicles and fertilize them. Fertilized eggs are cultured and then cryopreserved for future embryo transfer. Currently, we recurit patients diagnosed with POI, or Ovarian resistance syndrome (ORS). The procedure can also be: Only superficial cut of the ovarian cortex by laparoscopy or laparotomy, without taking ovary outside or cultured with medium.

NCT ID: NCT02181595 Terminated - Clinical trials for Ovarian Insufficiency

Deep Reading as a Contemplative Practice for Women With Primary Ovarian Insufficiency

Start date: July 2, 2014
Phase: Phase 1
Study type: Interventional

Background: - Women with Primary Ovarian Insufficiency (POI) have ovaries that stopped working normally before they turned 40. This usually causes infertility, which challenges many women with the condition to ask themselves, Why me? This kind of question is about our human existence, or what some call an existential view of life. Researchers have learned that spirituality and finding existential purpose help women with POI. So does meeting other women with the same problem. Researchers want to find new ways to help women with POI cope with it. Objective: - To develop and test a practice for women with POI called Deep Reading. Eligibility: - Women enrolled in another POI protocol, who can read and speak English. Design: - Participants will first have an individual visit or phone call. They will describe spiritual or existential practices they have done. They will also answer questions about spiritual and existential health and daily functioning. - They will join a group for 6 weekly sessions. Each session will be 60 90 minutes. - In each group session, a coordinator will teach participants about Deep Reading. They will read a piece of up to 1000 words. They will think about the piece and then talk about it with the group. - Between sessions, participants will practice Deep Reading at least once for 15 20 minutes on their own. They will check in once with another group member. They will keep a log of these activities. - After session 3, participants will answer questions online about wellbeing and satisfaction. - At session 6, participants will answer questions online about wellbeing. They will answer questions about their overall experience. - One and 3 months after the sessions end, participants will again complete online wellbeing questionnaires and report on their continued practice of Deep Reading.